Pain management stories

Jul 29, 2026

Latigo reports positive mid-stage trial results for pain drug competing with Vertex's Journavx

Latigo has announced successful mid-stage clinical trial results for its non-opioid pain medication, positioning it as a potential competitor to Vertex Pharmaceuticals' pain drug Journavx in a field historically marked by development failures.

Jul 29, 20261 source

00

Jul 24, 2026

FDA Approves First Over-the-Counter Combination Pill of Tylenol and Naproxen for Pain Relief

The U.S. Food and Drug Administration approved a nonprescription fixed-dose combination pill containing acetaminophen (650 mg) and naproxen sodium (220 mg), marketed as Tylenol with Naproxen by Kenvue. The medication provides up to 12 hours of pain relief for patients aged 12 and older.

Jul 24, 20269 sources

00

Related timelines

Pain management stories

Latigo reports positive mid-stage trial results for pain drug competing with Vertex's Journavx

FDA Approves First Over-the-Counter Combination Pill of Tylenol and Naproxen for Pain Relief

Related timelines

US Congress

Venture capital funding

Iran War

Strait of Hormuz blockage

Trump administration